Pulmonx Total Liabilities 2019-2025 | LUNG

Pulmonx total liabilities from 2019 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Pulmonx Annual Total Liabilities
(Millions of US $)
2024 $77
2023 $59
2022 $40
2021 $42
2020 $38
2019 $36
2018 $42
Pulmonx Quarterly Total Liabilities
(Millions of US $)
2025-06-30 $78
2025-03-31 $73
2024-12-31 $77
2024-09-30 $73
2024-06-30 $71
2024-03-31 $54
2023-12-31 $59
2023-09-30 $59
2023-06-30 $59
2023-03-31 $57
2022-12-31 $40
2022-09-30 $39
2022-06-30 $41
2022-03-31 $41
2021-12-31 $42
2021-09-30 $44
2021-06-30 $39
2021-03-31 $39
2020-12-31 $38
2020-09-30 $278
2020-06-30 $0
2020-03-31 $0
2019-12-31
2019-09-30 $0
2018-12-31 $42
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.069B $0.084B
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $48.395B 59.05
Tempus AI (TEM) United States $14.291B 0.00
Doximity (DOCS) United States $11.985B 53.33
Hims & Hers Health (HIMS) United States $9.884B 76.72
IRhythm Technologies (IRTC) United States $5.815B 0.00
Hinge Health (HNGE) United States $3.560B 0.00
Privia Health (PRVA) United States $3.071B 227.46
Heartflow (HTFL) United States $2.895B 0.00
Inspire Medical Systems (INSP) United States $2.406B 39.82
Enovis (ENOV) United States $1.800B 9.51
10x Genomics (TXG) United States $1.679B 0.00
Omnicell (OMCL) United States $1.642B 32.79
Clover Health Investments (CLOV) United States $1.520B 0.00
Schrodinger (SDGR) United States $1.455B 0.00
Azenta (AZTA) United States $1.400B 61.08
Phreesia (PHR) United States $1.358B 0.00
Claritev (CTEV) United States $1.071B 0.00
Evolent Health (EVH) United States $0.746B 0.00
Fulgent Genetics (FLGT) United States $0.697B 0.00
Butterfly Network (BFLY) United States $0.632B 0.00
Talkspace (TALK) United States $0.576B 114.67
Veradigm (MDRX) United States $0.520B 0.00
Zepp Health (ZEPP) Netherlands $0.505B 0.00
Standard BioTools (LAB) United States $0.438B 0.00
Carlsmed (CARL) United States $0.322B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.305B 0.00
TruBridge (TBRG) United States $0.290B 50.76
CapsoVision (CV) United States $0.226B 0.00
MDxHealth SA (MDXH) Belgium $0.223B 0.00
Outset Medical (OM) United States $0.223B 0.00
Health Catalyst (HCAT) United States $0.215B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.186B 0.00
Nyxoah SA (NYXH) Belgium $0.170B 0.00
CareCloud (CCLD) United States $0.125B 5.67
EUDA Health Holdings (EUDA) Singapore $0.119B 0.00
American Well (AMWL) United States $0.074B 0.00
NetraMark Holdings (AINMF) Canada $0.073B 0.00
P3 Health Partners (PIII) United States $0.060B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
111 (YI) China $0.038B 0.00
Evaxion - (EVAX) Denmark $0.036B 0.00
Precipio (PRPO) United States $0.033B 0.00
Lunai Bioworks (LNAI) United States $0.027B 0.00
Predictive Oncology (POAI) United States $0.027B 0.00
Zhongchao (ZCMD) China $0.018B 0.00
Healthcare Triangle (HCTI) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Movano (MOVE) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.002B 0.00
MSP Recovery (MSPR) United States $0.001B 0.00